THE ROLE OF MOMETASONE FUROATE AQUEOUS NASAL SPRAY IN THE TREATMENT OF ADENOID HYPERTROPHY IN CHILDRENS OF 5-12 YEARS- AN OBSERVATIONAL STUDY

Abstract

Background: One of the common causes for nasal obstruction in children is adenoid hypertrophy which is a common indication for surgical removal due to associated diseases.
Objectives: The aim of the current study was to determine the effectiveness of mometasone furoate nasal spray in treatment of children with adenoid hypertrophy.
Methods: a prospective study comprised about analysis of mometasone furoate (MF) nasal spray for the treatment of adenoid hypertrophy on 72 children of age range between 5-12 years. MF nasal spray was prescribed to all patients for 3 hourly everyday for 3 months. Symptoms like Adenoid hypertrophy grading, nasal obstruction, snoring and interruption in mouth breathing were evaluated Pre and post treatment. Nasal obstruction was counted as mild, moderate and severe. Presence of snoring and interruption in mouth breathing were observed. The follow up was taken on 15th day, at the end of 1st month and 3rd month.
Results: Few common symptoms of adenoid hypertrophy were observed prior and after the treatment. Follow up period was evaluated on 15th day, 1 month and 3 month. Out of 72 patients, only 12 (16.66%) patients showed nasal obstruction by 3rd month, 9 (12.50%) patients had increase in adenoid size, 7 (9.72%) patients showed snoring and 10 (13.88%) patients showed interrupted mouth breathing. All the findings were statistically significant. Snoring was found to be more relieved symptom in all group patients than any other symptoms i.e. 7 (9.72%) patients.
Conclusion: Long term MF nasal spray treatment has good efficacy in treatment of nasal obstruction due to adenoid hypertrophy.
Keywords: adenoid hypertrophy, adenoidectomy, nasal obstruction, mometasone furoate (MF) nasal spray.